Schedule 13G ownership disclosure

VYNE THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 92941V308

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Cormorant Asset Management, LP

    Shares: 1,370,938.00 · Class: 8.23%

  • Bihua Chen

    Shares: 1,370,938.00 · Class: 8.23%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-003435
Form type
SCHEDULE 13G/A
Filer
Cormorant Asset Management, LP
CIK
CIK 1583977
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub